Showing results (171-180 of 697) with videos related to
Sort By:
Pageof 70
Haematologica|August 2, 2016
Immunoparesis status in immunoglobulin light chain amyloidosis at diagnosis affects response and survival by regimen typeEli Muchtar, Angela Dispenzieri, Shaji K Kumar, et al.Clinical Lymphoma, Myeloma & Leukemia|June 18, 2026
Ixazomib, Cyclophosphamide, and Dexamethasone (ICd), With or Without Daratumumab in Relapsed Multiple MyelomaShaji Kumar, Betsy Knopf, Erik Asmus, et al.Blood|June 9, 2025
Eliminating the need for sequential confirmation of response in multiple myelomaJean-Sébastien Claveau, Prashant Kapoor, Moritz Binder, et al.European Journal of Haematology|February 8, 2014
Outcomes and treatments of patients with immunoglobulin light chain amyloidosis who progress or relapse postautologous stem cell transplantRahma Warsame, Soo Mee Bang, Shaji K Kumar, et al.Blood|July 14, 2011
Reduction in plasma cell proliferation after initial therapy in newly diagnosed multiple myeloma measures treatment response and predicts improved survivalJeremy T Larsen, Cheng E Chee, John A Lust, et al.European Journal of Haematology|September 3, 2013
Responsiveness of cytogenetically discrete human myeloma cell lines to lenalidomide: lack of correlation with cereblon and interferon regulatory factor 4 expression levelsAlexandra J Greenberg, Denise K Walters, Shaji K Kumar, et al.British Journal of Haematology|November 20, 2002
Helicobacter pylori infection and monoclonal gammopathy of undetermined significanceS Vincent Rajkumar, Robert A Kyle, Matthew F Plevak, et al.Journal of the American Society of Nephrology : JASN|March 9, 2021
Safety and Efficacy of Daratumumab in Patients with Proliferative GN with Monoclonal Immunoglobulin DepositsLadan Zand, S Vincent Rajkumar, Nelson Leung, et al.Haematologica|May 12, 2004
Effect of statins, smoking and obesity on progression of monoclonal gammopathy of undetermined significance: a case-control studyMichael A Thompson, Robert A Kyle, L Joseph Melton, et al.Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|March 5, 2005
Fracture risk with multiple myeloma: a population-based studyL Joseph Melton, Robert A Kyle, Sara J Achenbach, et al.Pageof 70